Tilray Brands, Inc. (TLRY)
TLRYPrice: $6.37
Fair Value: 🔒
🔒score
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution... more
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of... more
Description
Shares
| Market Cap | $740.71M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Country | CA | CEO | Irwin David Simon |
| IPO Date | 2018-07-19 | CAGR | — |
| Employees | 2,650 | Website | www.tilray.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
TLRY chart loading...
Fundamentals
Technicals
| Enterprise Value | $883.76M | P/E Ratio | -0.51 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 0.67 | P/B Ratio | 0.43 |
| P/CF Ratio | -12.01 | P/FCF Ratio | -8.09 |
| EPS | $-2.42 | EPS Growth 1Y | 21.76% |
| EPS Growth 3Y | -54.51% | EPS Growth 5Y | 6.37% |
| Revenue Growth 1Y | -3.49% | Gross Margin | 0.28% |
| Operating Margin | -1.84% | Profit Margin | -1.64% |
| ROE | -0.91% | ROA | -0.87% |
| ROCE | -1.12% | Current Ratio | 2.79 |
| Quick Ratio | 1.66 | Cash Ratio | 0.79 |
| Debt/Equity | 0.14 | Interest Coverage | -91.93 |
| Altman Z Score | -4.51 | Piotroski Score | 5 |